The Genetics of CASK-Related Disorders
At a Glance
CASK-related disorders are caused by changes in the CASK gene on the X chromosome. The change may be new or inherited, and its type alone cannot predict a child’s abilities, seizures, or adult outcome; genetic counseling and parental testing help clarify recurrence risk.
At its core, a CASK-related disorder is caused by a change—called a pathogenic variant (often referred to as a mutation)—in the CASK gene. This gene is located on the X chromosome, which is one of the two chromosomes that determine biological sex [1]. Understanding the biology of this gene and how it is passed down can help you make sense of why children with the same diagnosis can have such different experiences.
The Role of CASK in the Brain
The CASK gene is like a master architect for the brain. It provides instructions for making the CASK protein, which acts as a “scaffold” that holds other important proteins in place [2].
- Building Connections: CASK helps organize the synapses, which are the communication points between nerve cells (neurons) [3].
- Supporting Survival: The protein is particularly important for the survival of cells in the cerebellum (the part of the brain that controls balance and movement). Without enough functional CASK protein, these cells may not develop correctly, leading to the small brain structures seen in MICPCH [4][5].
X-Linked Inheritance: Why Sex Matters
Because the CASK gene is on the X chromosome, the condition affects individuals with two X chromosomes (usually females) and individuals with one X chromosome (usually males) differently.
- Females (XX): Females have two X chromosomes. If one has a CASK variant, the other “healthy” X chromosome can often still produce the protein. Through a natural process called X-inactivation, each cell “turns off” one X chromosome. However, this is not a perfect protective shield. X-inactivation can be “skewed,” meaning the body might turn off the healthy X chromosome more often than the altered one, leaving a female with substantial symptoms and severe challenges like MICPCH [6][7].
- Males (XY): Males have only one X chromosome. If that X chromosome has a variant, they have no “backup” copy of the gene [8]. This is why severe variants can be very impactful for males. Some males, however, have somatic mosaicism (where the variant is present in only some cells of their body, not all), which can lead to milder symptoms [9].
Types of Variants
Geneticists look at the type of variant to understand the biology, but it is critical to know that variant type alone cannot perfectly predict your child’s abilities, seizure course, or adult outcome.
- Loss-of-Function: The gene produces little to no working protein. Historically, this has been strongly associated with MICPCH (smaller brain structures) and severe developmental delays [7].
- Missense: A single “letter” in the genetic code is swapped. While previously thought to just mildly change the protein’s shape (often associated with the milder Najm type), we now know that some missense changes can substantially impair or destroy the protein’s function entirely [9].
- Splice Site or Copy-Number Changes: These affect how the genetic instructions are “cut and pasted” together, or involve missing/extra chunks of the gene [10]. The severity varies widely [11].
Where Did It Come From? Inheritance and Family Planning
One of the first questions parents ask is about inheritance.
- De Novo Variants: In many cases, the CASK variant is de novo, meaning it is a “new” change that happened early in the child’s development and was not inherited from either parent [8][12].
- Inherited Variants and Carrier Mothers: Sometimes, a mother is a carrier of the variant. A heterozygous mother may have no symptoms at all, or she may have meaningful CASK-related features (like mild learning difficulties) [13][14]. If a mother carries the pathogenic variant, each pregnancy has a 50% chance of inheriting the altered gene.
- Germline Mosaicism: Even if a variant appears de novo in a child and parents test negative in their blood, there is a very small but nonzero chance of germline mosaicism—where the variant is hidden in the parent’s egg or sperm cells.
Because of these complexities, meeting with a genetic counselor is highly recommended. They can arrange appropriate parental testing and discuss the exact recurrence risks for your family [8]. While the genetic report provides the “why” behind the diagnosis, your child’s daily progress and their response to therapies remain the most helpful guides for their individual journey [15][16].
Common questions in this guide
What causes a CASK-related disorder?
How is a CASK-related disorder passed down in families?
What do the different CASK variant types mean?
Can a parent carry a CASK variant without having symptoms?
What does mosaicism mean in a CASK genetic report?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on X-linked intellectual disability, Najm type.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my child's specific variant classified as 'missense,' 'loss-of-function,' or a 'deletion/duplication'?
- 2.Was this pathogenic variant found to be 'de novo' in my child, or did testing show that I (or the other parent) am a carrier?
- 3.Given the X-linked nature of this condition, what is the exact risk of this recurring in future pregnancies?
- 4.Does my child's genetic report mention 'mosaicism,' and how might that influence their specific symptoms?
- 5.Can you explain which domains or parts of the CASK protein are affected by this specific variant?
References
References (16)
- 1
Clinical and genetic spectrum of CASK-related disorders in Chinese patients.
Chen Y, Cao J, Li J, et al.
Journal of neurology 2026; (273(6)).
PMID: 42133085 - 2
Patient-Derived Variants Define Constraints for Ligand Binding at the PDZ Domain of CASK.
Tibbe D, Hönck HH, Bhatia N, et al.
Journal of neurochemistry 2025; (169(12)):e70303 doi:10.1111/jnc.70303.
PMID: 41321276 - 3
CASK stabilizes neurexin and links it to liprin-α in a neuronal activity-dependent manner.
LaConte LE, Chavan V, Liang C, et al.
Cellular and molecular life sciences : CMLS 2016; (73(18)):3599-621 doi:10.1007/s00018-016-2183-4.
PMID: 27015872 - 4
Structural Analysis Implicates CASK-Liprin-α2 Interaction in Cerebellar Granular Cell Death in MICPCH Syndrome.
Guo Q, Kouyama-Suzuki E, Shirai Y, et al.
Cells 2023; (12(8)) doi:10.3390/cells12081177.
PMID: 37190086 - 5
Complete loss of the X-linked gene CASK causes severe cerebellar degeneration.
Patel PA, Hegert JV, Cristian I, et al.
Journal of medical genetics 2022; (59(11)):1044-1057 doi:10.1136/jmedgenet-2021-108115.
PMID: 35149592 - 6
The Competitive Loss of Cerebellar Granule and Purkinje Cells Driven by X-Linked Mosaicism in a Female Mouse Model of CASK-Related Disorders.
Mori T, Zhou M, Kunugitani K, et al.
Cells 2025; (14(10)) doi:10.3390/cells14100735.
PMID: 40422238 - 7
Pathogenic variants in CASK: Expanding the genotype-phenotype correlations.
Dubbs H, Ortiz-Gonzalez X, Marsh ED
American journal of medical genetics. Part A 2022; (188(9)):2617-2626 doi:10.1002/ajmg.a.62863.
PMID: 35670295 - 8
Clinical heterogeneity and diagnostic challenges in CASK-related neurodevelopmental disorders: a longitudinal observational study.
Pacheva IH, Timova E, Todorov T, et al.
Frontiers in psychiatry 2026; (17()):1804756 doi:10.3389/fpsyt.2026.1804756.
PMID: 42517139 - 9
Phenotypic and molecular insights into CASK-related disorders in males.
Moog U, Bierhals T, Brand K, et al.
Orphanet journal of rare diseases 2015; (10()):44 doi:10.1186/s13023-015-0256-3.
PMID: 25886057 - 10
Dissecting CASK: Novel splice site variant associated with male MICPCH phenotype.
Silveira KC, Ambrose A, Athey T, et al.
Clinical genetics 2024; (106(6)):764-768 doi:10.1111/cge.14610.
PMID: 39212003 - 11
A de novo splice site mutation in CASK causes FG syndrome-4 and congenital nystagmus.
Dunn P, Prigatano GP, Szelinger S, et al.
American journal of medical genetics. Part A 2017; (173(3)):611-617 doi:10.1002/ajmg.a.38069.
PMID: 28139025 - 12
A de novo in-frame deletion of CASK gene causes early onset infantile spasms and supratentorial cerebral malformation in a female patient.
Bozarth X, Foss K, Mefford HC
American journal of medical genetics. Part A 2018; (176(11)):2425-2429 doi:10.1002/ajmg.a.40429.
PMID: 30289607 - 13
Case Report: Identification of a novel CASK missense variant in a Chinese family with MICPCH.
Zhang R, Jia P, Yao Y, Zhu F
Frontiers in genetics 2022; (13()):933785 doi:10.3389/fgene.2022.933785.
PMID: 36092876 - 14
A novel CASK mutation identified in siblings exhibiting developmental disorders with/without microcephaly.
Seto T, Hamazaki T, Nishigaki S, et al.
Intractable & rare diseases research 2017; (6(3)):177-182 doi:10.5582/irdr.2017.01031.
PMID: 28944139 - 15
Intellectual Disability and Microcephaly With Pontine and Cerebellar Hypoplasia in Adults: Severity Spectrum and Diversity of the CASK Gene Aberrations.
Obara K, Abe E, Toyoshima I
Cureus 2026; (18(5)):e109777 doi:10.7759/cureus.109777.
PMID: 42367460 - 16
The neurodevelopmental spectrum of CASK-related disorder.
Martin J, Mavrogalou-Foti A, Eck J, et al.
Journal of neurodevelopmental disorders 2025; (17(1)):60 doi:10.1186/s11689-025-09643-3.
PMID: 41039189
This page explains CASK-related disorder genetics for informational purposes only and does not constitute medical advice. A genetic counselor or specialist should interpret your child’s result and discuss inheritance and recurrence risk for your family.